Literature DB >> 11257276

Interaction of the glutathione S-transferase genes and cigarette smoking on risk of lower extremity arterial disease: the Atherosclerosis Risk in Communities (ARIC) study.

R Li1, A R Folsom, A R Sharrett, D Couper, M Bray, H A Tyroler.   

Abstract

Glutathione S-transferases M1 or T1 (GSTM1/GSTT1) affect the body's ability either to detoxify or to activate chemicals in cigarette smoke. Cigarette smoking increases the risk of lower extremity arterial disease (LEAD). We conducted a cross-sectional study to evaluate a hypothesized interaction of the genetic polymorphisms of GSTM1 and T1 with cigarette smoking in the risk of LEAD in the ARIC study. A stratified-random sample, including 212 LEAD cases (ankle-brachial index <0.9 in men or <0.85 in women) and 1277 non-cases, was selected from the ARIC cohort of 12041 middle-aged participants free of CHD, transient ischemic attack and stroke at baseline (1987-1989). Overall, the differences in the frequencies of GSTM1-0 and GSTT1-0 (the homozygous deletion genotype) were not statistically significant between cases and non-cases (44 vs. 41% and 28 vs. 18%). However, smoking was more prevalent among LEAD cases than non-cases. The results suggest that the non-deletion genotype GSTM1-1 interacts with smoking to increase the risk of LEAD, but this interaction was not statistically significant. The functional genotype GSTT1-1 was significantly associated with increased risk of LEAD given smoking after adjustment for other risk factors. In individuals with GSTT1-1, the odds ratios (ORs) (95% confidence intervals) of LEAD were 3.6 (1.4, 9.0) for current smoking and 5.0 (1.9, 13.0) for 20+ pack-years. However, in those with GSTT1-0, the ORs were 0.8 (0.2, 2.8) for current smoking and 0.6 (0.1, 2.1) for 20+ pack-years. The interaction was significant (P<0.05) on the additive scale for current smoking and on both the additive and multiplicative scales for 20+ pack-years. Among non-smokers, GSTT1-1 was not associated with LEAD. The results suggest that the GSTT1-1 polymorphism may be a susceptibility factor modifying the risk of LEAD associated with cigarette smoking.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11257276     DOI: 10.1016/s0021-9150(00)00582-7

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  25 in total

1.  Tobacco use: a chronic illness?

Authors:  Naomi L Hudson; David M Mannino
Journal:  J Community Health       Date:  2010-10

2.  Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Craig R Lee; Kari E North; Molly S Bray; Myriam Fornage; John M Seubert; John W Newman; Bruce D Hammock; David J Couper; Gerardo Heiss; Darryl C Zeldin
Journal:  Hum Mol Genet       Date:  2006-04-04       Impact factor: 6.150

3.  CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Craig R Lee; Kari E North; Molly S Bray; David J Couper; Gerardo Heiss; Darryl C Zeldin
Journal:  Pharmacogenet Genomics       Date:  2007-05       Impact factor: 2.089

4.  Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  C R Lee; K E North; M S Bray; D J Couper; G Heiss; D C Zeldin
Journal:  Clin Pharmacol Ther       Date:  2007-05-09       Impact factor: 6.875

Review 5.  The genetic basis of peripheral arterial disease: current knowledge, challenges, and future directions.

Authors:  Iftikhar J Kullo; Nicholas J Leeper
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

6.  Outcome-dependent sampling: an efficient sampling and inference procedure for studies with a continuous outcome.

Authors:  Haibo Zhou; Jianwei Chen; Tiina H Rissanen; Susan A Korrick; Howard Hu; Jukka T Salonen; Matthew P Longnecker
Journal:  Epidemiology       Date:  2007-07       Impact factor: 4.822

7.  Effects of glutathione S-transferase T1 and M1 deletions on advanced carotid atherosclerosis, oxidative, lipid and inflammatory parameters.

Authors:  Maja Zivković; Aleksandra Stanković; Tamara Djurić; Igor Končar; Ana Kolaković; Vladimir Djurdjević; Lazar Davidović; Dragan Alavantić
Journal:  Mol Biol Rep       Date:  2014-01-10       Impact factor: 2.316

8.  The association between GSTT1, M1, and P1 polymorphisms with coronary artery disease in Western Iran.

Authors:  Hamid Nomani; Hadi Mozafari; Shahrokh Mohamadzadeh Ghobadloo; Zohreh Rahimi; Asad Vaisi Raygani; Mehr Ali Rahimi; Asghar Fadaei Haghi; Ali Asghar Keshavarz
Journal:  Mol Cell Biochem       Date:  2011-04-16       Impact factor: 3.396

9.  Age-related macular degeneration and genetic polymorphisms of glutathione S-transferases M1 (GSTM1) and T1 (GSTT1).

Authors:  Hasan Othman; Ahmad Reza Gholampour; Iraj Saadat; Majid Farvardin-Jahromoi; Mostafa Saadat
Journal:  Mol Biol Rep       Date:  2011-06-24       Impact factor: 2.316

Review 10.  Peripheral Artery Disease and Aortic Disease.

Authors:  Michael H Criqui; Victor Aboyans; Matthew A Allison; Julie O Denenberg; Nketi Forbang; Mary M McDermott; Christina L Wassel; Nathan D Wong
Journal:  Glob Heart       Date:  2016-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.